Organizational predictors of pharmacological innovation adoption: The case of disulfiram

Hannah K. Knudsen, Paul M. Roman, Lori J. Ducharme, J Aaron Johnson

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

The research-to-practice gap in substance abuse treatment, particularly with regard to pharmacological innovations, necessitates the consideration of organizational characteristics that facilitate the adoption of innovations. Using data from a nationally representative sample of 394 privately funded substance abuse treatment centers, this study examines variation in the adoption of disulfiram in terms of organizational structure, workforce professionalism, and treatment philosophy. Logistic regression results indicated that hospital-based centers were significantly more likely to use disulfiram than freestanding treatment programs. In addition, the percentage of counselors with master's degrees and the percentage of certified/licensed counselors were positively associated with the likelihood of disulfiram utilization. Treatment centers that emphasized confrontational group therapy and spirituality were less likely to use disulfiram, while the adoption of disulfiram was more likely in centers that emphasized a medical model of addiction.

Original languageEnglish (US)
Pages (from-to)559-574
Number of pages16
JournalJournal of Drug Issues
Volume35
Issue number3
Publication statusPublished - Jun 1 2005
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Health(social science)
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health

Cite this